Member Info for mol42

this may be another one (there are a number of these strains)

https://m.facebook.com/vaqueriatresmonjitas/videos/yogur-bebible-probi%C3%B3tico-lactobacillus-plantarum/1038327030429276/

https://www.youtube.com/watch?v=l5kOmCzPL5I

https://www.tresmonjitas.com/yogur-bebible/

mol

probably news to all at opti and pbx this evening

they read this bb - just sometimes we're ahead of the game

bw all

mol

you may be wondering what this has to do with opti - albeit probably should be on PBX bb - lol

https://optibiotix.com/supporting-partners-at-key-events-through-2021/

ProBiotix, the probiotic division of OptiBiotix, attended the show in support of distributing partners, leading biotech ingredient hub Sacco System, and innovating health solution developer, Kappa Biosciences.

At Vitafoods, the ProBiotix team spoke to customers – both existing and prospective – about the continual development of its flagship products, LPLDL® and CholBiome®.

Representing the future of high-performance microbiome modulation, LPLDL® harnesses the microbiome-liver axis to positively influence the gut microbiome, using a naturally occurring strain of beneficial bacteria, Lactobacillus plantarum. The ingredient offers exceptional survivability through the manufacturing and digestive processes, making it a profoundly valuable choice for nutritional supplement and functional food developers.

CholBiome® is a collection of consumer-ready supplements that harnesses LPLDL® as its active ingredient. Aimed at transforming the way cardiovascular health is approached, the supplement offers a holistic alternative to pharmaceutical treatments.

but Kappa has been bought

https://balchem.com/wp-content/uploads/2022/06/Balchem-Kappa-Press-Release-6-21-22.pdf

https://balchem.com/

https://balchem.com/blog/balchem-corporation-completes-acquisition-of-kappa-bioscience-as/

mol

Posted on PBX but just thought I'd post here too

https://www.nutritioninsight.com/news/study-illuminates-link-between-gut-microbiome-and-heart-failure.html

and of course

https://optibiotix.com/trusting-the-gut/

mol

a recent study 21 june 2022

https://www.nutritioninsight.com/news/study-illuminates-link-between-gut-microbiome-and-heart-failure.html

https://optibiotix.com/trusting-the-gut/

mol

continuing to list Windmill appetite gummies in top five - albeit with a different heading

Best Weight Loss Gummies to burn Body Fat Instantly (2022)

https://theislandnow.com/blog-112/best-slimming-gummies/

We found countless satisfied customers that used appetite control gummies and lost weight. This product is an excellent appetite suppressant, thanks to its Slimbiome main ingredient. Slimbiome is a patented element composed of a few components, including Glucomannan.

Besides Slimbiome, the gummies contain several other ingredients. You’ll get 4g of carbohydrate and 2g of dietary fiber in one serving size. Moreover, you’ll consume only 10 calories.

These gummies are also as potent and effective as the already-mentioned Thermo gummies. So, the brand suggests that its customers consume 2 pieces per day. Since they’re packed in a 60-piece container, you’ll get a 1-month supply.

Furthermore, the gummies have an excellent raspberry flavor obtained from real fruit. Most importantly, they don’t contain any artificial flavors or colors.

Their main purpose is to suppress your appetite and food cravings. That’s why after consuming the recommended serving size, you’ll feel full; hence you’ll reduce your daily calorie intake. Moreover, these gummies are probiotic. This means that they can stimulate positive bacteria to grow, which eventually leads to improved gut health.

The gummies are suitable for both men and women who use weight management or fasting plans.

Pros
A comprehensive assortment of vitamins, minerals, supplements, anti-aging nutrition, etc.
The products are available in multiple forms for better customer convenience
Available in 150,000 retailers across the world
Effective and natural gummies
Key ingredient Slimbiome is a powerful cravings suppressant
The gummies improve digestion and gut health

Cons
The appetite-control gummies are available only in raspberry flavor

bit of licence in heading but continuing exposure

mol

Bit of exposure

10 ways to improve your health and beauty regimen

Here’s a round up of 10 companies that could help you feel and look good

https://www.standard.co.uk/escapist/10-ways-to-improve-your-health-and-beauty-regimen-b1006516.html

Think all weight management solutions are the same? Think again – the GoFigure® range is one of the only products of its kind in the UK that’s powered by SlimBiome®. When on a calorie-restricted diet, cravings can lead to a diet fail. Independent studies from the University of Roehampton and Oxford Brookes have shown that SlimBiome is a high-performance prebiotic fibre blend that can help promote a feeling of fullness, support weight loss and can have “a positive impact on gut microbiome”. Featuring SlimBiome, GoFigure hopes to make overindulgence a thing of the past.

Start your day with GoFigure porridge or try a GoFigure meal replacement shake in one of three available flavours. And if you need a snack on the go then GoFigure flapjacks are the perfect choice. Find the GoFigure range on optibiotix.online/gofigure, and receive 20% off with the code ES20 until 4 July 2022.

mol

Leeford Megaslim Meal Replacement

Pretty sure I noted this last summer but just thought I'd check up on it again and see if it was still on sale

https://www.leefordonline.in/product/564/megaslim-meal-replacement-drink-powder-vanilla-flavour-reduce-weight-sugar-free-and-gluten-free-10-sachet-30g-each

https://www.amazon.in/Megaslim-Replacement-Drinking-Enriched-Multivitamin/dp/B09F39Q5QJ/ref=sr_1_4?crid=NHFMJH3FJCLY&keywords=megaslim+meal&qid=1655747203&s=grocery&sprefix=%2Cgrocery%2C54&sr=1-4

it is indeed

however I have still to note any launches on Apollo online site as yet

https://www.optibiotix-ir.com/content/news/archive/2021/091221

https://optibiotix.com/optibiotix-launches-subsidiary-company-in-india/

suppose nearly 4 months on shouldn't come as a surprise to the long suffering.............

mol

who joined in May 2021 apparently

https://clasado.com/meet-the-team-dr-frederic-narbel/

which is hardly surprising perhaps after

https://www.optibiotix-ir.com/content/news/archive/2021/23-03-21

mol

along with Fred

https://clasado.com/corporate/

mol

I note Steven Riley has recently joined Per at Clasado

https://clasado.com/clasado-appoints-new-head-of-b2b-and-corporate-marketing-steven-riley/

just a bit of info

mol

Exactly the same for Sbtx and Opti @ 21.50 today

MC

sbtx £33m

opti £19m

mol

for completeness

a letter of appointment between the Company and Adam Reynolds dated 31 March 2022, pursuant to which Mr Reynolds was appointed as a non-executive Director and chairman of the Company for an annual fee of £30,000, payable monthly in arrears. Mr Reynolds is required to devote such time as is necessary for the carrying out of his duties as a non-executive Director of the Company. The appointment is terminable on 3 months’ notice on either side, save that Mr Reynolds cannot terminate on notice at any time within the first 12 months of the appointment. No compensation is payable for loss of office and the appointment may be terminated immediately if, among other things, Mr Reynolds is in material breach of the terms of the appointment. The appointment letter supersedes and replaces a letter of appointment made between Mr Reynolds and ProBiotix dated 21 September 2018 as related to Mr Reynolds’ appointment as a non-executive director of ProBiotix;

6.1.4 a letter of appointment between the Company and Marco Caspani dated 31 March 2022, pursuant to which Mr Caspani was appointed as a non-executive Director of the Company for an annual fee of £20,000, payable monthly in arrears. Mr Caspani is required to devote such time as is necessary for the carrying out of his duties as a non-executive Director of
the Company. The appointment is terminable on 3 months’ notice on either side, save that Caspani cannot terminate on notice at any time within the first 12 months of the appointment. No compensation is payable for loss of office and the appointment may be terminated immediately if, among other things, Mr Caspani is in material breach of the terms of the appointment.

mol

We await of course how the separate listing and salary awarded in PBX translates to opti salary package and hours worked
by our CEO - however this will be in year end to 31 Dec 2022 - due by june 2023

methinks no reduction but a perhaps substantial increase over both companies - just an opinion

mol

bit of info which I posted on PBX board

Just an observation from admission document

The Group has entered into service agreements and letters of appointment as follows:

6.1.1 an agreement between Stephen O’Hara and ProBiotix dated 31 March 2022, pursuant to which Mr O’Hara agreed to act as Chief Executive Officer of ProBiotix on a part time basis committing a minimum of 18½ hours per week. In the absence of breach, the appointment is terminable on six months’ notice on either side. The salary payable to Mr O’Hara is £106,000 per annum. Mr O’Hara has agreed to post termination restrictions on competing activity, which commence on termination of the appointment (such that no period of gardening leave shall be counted as part of the restricted period). Mr O’Hara previously carried out duties for ProBiotix as part of shared services with OptiBiotix;

6.1.2 an agreement between Mikkel Hvid-Hansen and ProBiotix dated 31 March 2022, pursuant to which Mr Hvid-Hansen agreed to act as Commercial Director of ProBiotix. In the absence of breach, the appointment is terminable on three months’ notice on either side. The salary payable to Mr Hvid-Hansen is €175,000 per annum. Mr Hvid-Hansen has agreed
to post termination restrictions on competing activity, which commence on termination (such that no period of gardening leave shall be counted as part of the restricted period). Mr Hvid-Hansen’s continuous employment with ProBiotix commenced on 3 February 2020 (which employment was governed under a prior service agreement, as has been replaced and superseded by the 31 March 2022 agreement);

presumably our full time executive will be paid far in excess of Stephen's salary - and therefore Stephen's reduced - I await with interest - unfortunately that will take until june 2023 - 5 months after the legal ownership of PBX shares transferred

mol

Just an observation from admission document

The Group has entered into service agreements and letters of appointment as follows:

6.1.1 an agreement between Stephen O’Hara and ProBiotix dated 31 March 2022, pursuant to which Mr O’Hara agreed to act as Chief Executive Officer of ProBiotix on a part time basis committing a minimum of 18½ hours per week. In the absence of breach, the appointment is terminable on six months’ notice on either side. The salary payable to Mr O’Hara is £106,000 per annum. Mr O’Hara has agreed to post termination restrictions on competing activity, which commence on termination of the appointment (such that no period of gardening leave shall be counted as part of the restricted period). Mr O’Hara previously carried out duties for ProBiotix as part of shared services with OptiBiotix;

6.1.2 an agreement between Mikkel Hvid-Hansen and ProBiotix dated 31 March 2022, pursuant to which Mr Hvid-Hansen agreed to act as Commercial Director of ProBiotix. In the absence of breach, the appointment is terminable on three months’ notice on either side. The salary payable to Mr Hvid-Hansen is €175,000 per annum. Mr Hvid-Hansen has agreed
to post termination restrictions on competing activity, which commence on termination (such that no period of gardening leave shall be counted as part of the restricted period). Mr Hvid-Hansen’s continuous employment with ProBiotix commenced on 3 February 2020 (which employment was governed under a prior service agreement, as has been replaced and superseded by the 31 March 2022 agreement);

presumably our full time executive will be paid far in excess of Stephen's salary - and therefore Stephen's reduced - I await with interest - unfortunately that will take until june 2023 - 5 months after the legal ownership of PBX shares transferred

mol

my understanding is that

whatever number of opti shares you held on 25th march - multiply by .554673 and that gives you the number of PBX that
are held by the nominee ( being Global Prime Partners Nominees Ltd, being the nominee recipient
of the OptiBiotix Dividend Shares) on your behalf and should in 2023 be then transferred from them to you at which point
you can then trade at whatever price PBX shares are then on the aquis exchange

I think aspex is confusing matters by presumably discounting the PBX current price by the in specie rate to get to the nominal 12p

that just isn't right

mol

Who has worked with our Commercial Director at Deerland (who purchased Bifodan in 2019)

https://gb.kompass.com/c/deerland-probiotics-enzymes-a-s/dk059564/

just a bit of info which may not have been obvious in rns releases

mol

Commercial Director Mikkel Hvid-Hansen

https://www.naturalpharmacybusiness.com/imag/npbjunejuly22/

mol

Our Commercial Director Mikkel Hvid-Hansen

https://www.naturalpharmacybusiness.com/imag/npbjunejuly22/

mol